A carregar...

Lesion Volume Change After Treatment With Tissue Plasminogen Activator Can Discriminate Clinical Responders From Nonresponders

BACKGROUND AND PURPOSE: A change in acute-to-chronic lesion volume has been proposed as a biomarker for stroke therapies. The objectives of this study were to determine the magnitude of lesion volume change after standard treatment with tissue plasminogen activator and to determine whether specific...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stroke
Main Authors: Merino, José G., Latour, Lawrence L., Todd, Jason W., Luby, Marie, Schellinger, Peter D., Kang, Dong-Wha, Warach, Steven
Formato: Artigo
Idioma:Inglês
Publicado em: 2007
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4747331/
https://ncbi.nlm.nih.gov/pubmed/17901392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.107.485995
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!